NASDAQ : NMTC

NeuroOne Medical Technologies Corporation — Company profile

Healthcare · Medical Devices · United States

Last price 0.9272 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 8.44M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology’s Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.

Details

NameNeuroOne Medical Technologies Corporation
SectorHealthcare
IndustryMedical Devices
Employees18
Founded2009
CeoDavid Rosa
CountryUnited States
ExchangeNASDAQ
Fiscal YearOctober - September
Reporting CurrencyUSD
IsinUS64130M3088
Cusip64130M308
Cik1500198
Sic3841
Stock TypeCommon Stock

Key executives

NameTitle
David A. Rosa M.D.President, Chief Executive Officer and Director
Christopher R. Volker CFAChief Financial Officer
Ronald W. McClurgSenior Advisor
Mark ChristiansonCo-Founder, Business Development Director and Medical Sales Liaison
Steven MertensChief Technology Officer
Emily JohnsChief Administrative Officer and General Counsel
Hijaz HarisVice President of Marketing
Dr. Parag G. Patil M.D., Ph.D.Chief Medical Advisor
David J. WambeckeChief Business Officer

Contact

Address7599 Anagram Drive, Eden Prairie, Minnesota 55344, United States
Phone952 426 1383
Websitehttps://nmtc1.com